・Anraku, Y., Kita, S., Onodera, T. et al.
Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants.
Commun Biol 8, 483 (2025) https://doi.org/10.1038/s42003-025-07827-0A01

・Sugiyama A, Minami M, Ugajin K, Inaba-Inoue S, Yabuno N, Takekawa Y, Xiaomei S, Takei S, Sasaki M, Nomai T, Jiang X, Kita S, Maenaka K, Hirose M, Yao M, Gooley PR, Moseley GW, Sugita Y, Ose T
Structural analysis reveals how tetrameric tyrosine-phosphorylated STAT1 is targeted by the rabies virus P-protein.
Sci Signal 18, 878 (2025) https://www.science.org/doi/10.1126/scisignal.ads2210A01

・Yamada C, Kuroki K, Maeda N, Watanabe H, Takahashi A, Maenaka K.
Enhanced effect of the immunosuppressive soluble HLA-G2 homodimer by site-specific PEGylation.
Sci Rep 15, 2509 (2025) https://www.nature.com/articles/s41598-024-85072-xA01

・Yajima H, Anraku Y, Kaku Y, Kimura KT, Plianchaisuk A, Okumura K, Nakada-Nakura Y, Atarashi Y, Hemmi T, Kuroda D, Takahashi Y, Kita S, Sasaki J, Sumita H;Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Maenaka K, Sato K, Hashiguchi T.
Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1.
Nat Commun 15, 8574 (2024) https://www.nature.com/articles/s41467-024-52808-2A01

・Fukuhara H, Yumoto K, Sako M, Kajikawa M, Ose T, Kawamura M, Yoda M, Chen S, Ito Y, Takeda S, Mwaba MH, Wang J, Hashiguchi T, Kamishikiryo J, Maita N, Kitatsuji C, Takeda M, Kuroki K, Maenaka K*.
Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination.
eLife, RP88929 (2024) https://elifesciences.org/reviewed-preprints/88929A01

・Tsujino S, Deguchi S, Nomai T, Padilla-Blanco M, Plianchaisuk A, Wang L, Begum MM, Uriu K, Mizuma K, Nao N, Kojima I, Tsubo T, Li J, Matsumura Y, Nagao M, Oda Y, Tsuda M, Anraku Y, Kita S, Yajima H, Sasaki-Tabata K, Guo Z, Hinay AA Jr, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Nasser H, Jonathan M, Putri O, Kim Y, Chen L, Suzuki R, Tamura T, Maenaka K, Irie T, Matsuno K, Tanaka S, Ito J, Ikeda T, Takayama K, Zahradnik J, Hashiguchi T, Fukuhara T, Sato K
Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant.
Microbiol Immunol, Online ahead of print (2024) https://onlinelibrary.wiley.com/doi/full/10.1111%2F1348-0421.13165 A01

・Tadokoro T, Tsuboi H, Nakamura K, Hayakawa T, Ohmura R, Kato I, Inoue M, Tsunoda SI, Niizuma S, Okada Y, Otsuguro S, Maenaka K*.
Thermostability and binding properties of single-chained Fv fragments derived from therapeutic antibodies.
Protein Sci 33, e5084 (2024) https://onlinelibrary.wiley.com/doi/10.1002/pro.5084A01